Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term enhancement. Found 10 abstracts

Younes A, Vose JM, Zelenetz AD, Smith MR, Burris HA, Ansell SM, Klein J, Halpern W, Miceli R, Kumm E, Fox NL, Czuczman MS. A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma. British Journal of Cancer. 2010 Dec;103(12):1783-7.   PMCID: PMCID: PMC3008610 [Available on 2011/12/7]
Arif JM, Dresler C, Clapper ML, Gairola CG, Srinivasan C, Lubet RA, Gupta RC. Lung DNA adducts detected in human smokers are unrelated to typical polyaromatic carcinogens. CHEMICAL RESEARCH IN TOXICOLOGY. 2006 Feb;19(2):295-9.
Das IJ. Forward dose perturbation at high atomic number interfaces in kilovoltage x-ray beams. Medical Physics. 1997 Nov;24(11):1781-7.
Gonen O, Mohebbi A, Stoyanova R, Brown TR. In vivo phosphorus polarization transfer and decoupling from protons in three-dimensional localized nuclear magnetic resonance spectroscopy of human brain. Magnetic Resonance in Medicine. 1997 Feb;37(2):301-6.
Hageboutros A, Hudes GR, Greene F, LaCreta FP, Brennan J, Odwyer PJ. Phase I trial of fluorouracil modulation by N-phosphonacetyl-L- aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer. Investigational New Drugs. 1997 Jan;15(2):139-45.
Xiang BS, Markham GD. The conformation of inosine 5'-monophosphate (IMP) bound to IMP dehydrogenase determined by transferred nuclear Overhauser effect spectroscopy. Journal of Biological Chemistry. 1996 Nov;271(44):27531-5.
Halberg FE, Cosmatis D, Gunderson LL, Noyes RD, Hanks GR, Buswell L, Nagorney DM, Coleman CN. Rtog Number-89-06 - a Phase-I Study to Evaluate Intraoperative, Radiation-Therapy and the Hypoxic Cell Sensitizer Etanidazole in Locally Advanced Malignancies. International Journal of Radiation Oncology Biology Physics. 1994 Jan;28(1):201-6.
Dabrow MB, Katz H, Odwyer PJ, Afshar C, Glusker JP. Molecular Dimensions and Properties of N- 1-(2-Hydroxyethyl)-2- Nitro-1h-Imidazol-1-Yl Acetamide(Sr2508). Archives of biochemistry and biophysics. 1993 Apr;302(1):259-64.
Odwyer PJ, Lacreta FP, Walczak J, Cox T, Litwin S, Hoffman JP, Zimny M, Comis RL. Phase-I Pharmacokinetic Biochemical-Study of the Nitroimadazole Hypoxic Cell Sensitizer Sr2508 (Etanidazole) in Combination with Cyclophosphamide. British Journal of Cancer. 1993 Oct;68(4):756-66.
Odwyer PJ, Panting L, Lacreta FP, Clapper ML. Sr2508 (Etanidazole) Pharmacokinetics and Biochemical Effects in Tumor and Normal-Tissues of Scid Mice Bearing Ht-29 Human Colon Adenocarcinoma. Biochemical pharmacology. 1993 Oct 05;46(7):1251-6.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term enhancement

Last updated on Thursday, August 13, 2020